Leoncini L, Bellan C, De Falco G
Department of Human Pathology and Oncology, University of Siena, Siena, Italy.
Oncogene. 2006 Aug 28;25(38):5309-14. doi: 10.1038/sj.onc.1209619.
It appears more and more clear that retinoblastoma (RB) family of proteins represents key molecules in tumour suppression. This family consists of pRb/p105, p107 and pRb2/p130, which participate in a gene regulatory network that governs the cellular response to antimitogenic signals, and whose deregulation constitutes one of the hallmarks of cancer. Irrespective of their structural and biochemical similarities, RB proteins carry out different functional tasks. The expression of RB gene family in the reactive lymphoid tissues again confirms the different role of each member in cell cycle control and differentiation of normal cells. These different functional properties appear to be maintained in tumours lymphoid tissues, where alterations of the RB/p105 gene appear to be relatively rare. In this review, we will summarize the current knowledge about the role of the RB proteins in reactive and neoplastic lymphoid tissue.
越来越明显的是,视网膜母细胞瘤(RB)蛋白家族是肿瘤抑制中的关键分子。该家族由pRb/p105、p107和pRb2/p130组成,它们参与一个基因调控网络,该网络控制细胞对抗有丝分裂信号的反应,其失调是癌症的标志之一。尽管RB蛋白在结构和生化方面存在相似性,但它们执行不同的功能任务。RB基因家族在反应性淋巴组织中的表达再次证实了每个成员在正常细胞的细胞周期控制和分化中的不同作用。这些不同的功能特性似乎在肿瘤淋巴组织中得以保留,其中RB/p105基因的改变似乎相对罕见。在本综述中,我们将总结目前关于RB蛋白在反应性和肿瘤性淋巴组织中的作用的知识。